Protective alleles and precision healthcare in crewed spaceflight
- PMID: 39039045
- PMCID: PMC11263583
- DOI: 10.1038/s41467-024-49423-6
Protective alleles and precision healthcare in crewed spaceflight
Abstract
Common and rare alleles are now being annotated across millions of human genomes, and omics technologies are increasingly being used to develop health and treatment recommendations. However, these alleles have not yet been systematically characterized relative to aerospace medicine. Here, we review published alleles naturally found in human cohorts that have a likely protective effect, which is linked to decreased cancer risk and improved bone, muscular, and cardiovascular health. Although some technical and ethical challenges remain, research into these protective mechanisms could translate into improved nutrition, exercise, and health recommendations for crew members during deep space missions.
© 2024. The Author(s).
Conflict of interest statement
Christopher E. Mason is the Co-Founder of Onegevity Health. Daniela Bezdan is the Co-founder of Poppy Health, Inc. and CSO of Yuri GmbH. Stefania Giacomello is scientific advisor to 10x Genomics, which holds IP rights to the ST technology and holds stocks. George M. Church is an advisor to 10x Genomics, Colossal, Copernicus, etc, details here: v.ht/PHNc. The remaining authors declare no competing interests.
Figures



References
-
- Ruyters, G., Stang, K. Space medicine 2025 – A vision. REACH. 55–62 (2016).
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources